Description
Monitoreo de efectos extrapiramidales y metabólicos durante el tratamiento
Número de Registro:
Evaluar función hepática durante el tratamiento
PRINCIPIO ACTIVO: TRIOTOPIO OLODATEROL
CINITAPRIDA COMP. 1 MG. CAJA C/25 PIRIDOXINA 50.00 MG MECLIZINA 25.00 MG Monitoreo de efectos extrapiramidales ySUSTANCIA: CINITAPRIDA COMP. 1 MG. CAJA C 25 FABRICANTE: AMSA GENERICO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
